The hepatitis B vaccine which was, recently and, in my view, unnecessarily introduced into the UK immunisation schedule, has been shown to cause alopecia areata, an auto-immune disease causing hair loss.
The hepatitis B vaccine was introduced into the UK vaccine schedule in 2018 as part of a 6-in-1 vaccine. This is despite the fact that hepatitis B is exceptionally rare in children in the UK as it is only contracted through blood or sexual contact. Fewer than 10 children contracted the disease in the UK every year.
New research has linked the disease with alopecia areata, an auto-immune disease which causes hair loss.
The vaccine has already been linked with the disabling neurological disorder
multiple sclerosis. The scientists discovered that the vaccine shared certain similarities with cells of the immune system which may account for its tendency to cause auto-immune illness. The decision on whether to give a child any particular vaccine must be made by balancing the benefits with the risks. In the case of the hepatitis B vaccine it offers no benefits to the vast majority of children in the UK. However it carries significant risks. I believe the scales fall heavily on the side not to vaccinate.